Evommune (EVMN) Capital Leases (2024 - 2026)

Evommune (EVMN) has reported Capital Leases for 3 consecutive years, with $529000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Capital Leases changed N/A year-over-year to $529000.0; the TTM figure through Mar 2026 stood at $529000.0 (changed N/A YoY), while the FY2025 annual figure was $181000.0, down 66.17% from the prior year.
• Capital Leases rose to $529000.0 in Q1 2026 per EVMN's latest filing, from $181000.0 in the prior quarter.
• Across five years, Capital Leases topped out at $535000.0 in Q4 2024 and bottomed at $181000.0 in Q4 2025.
• Historically, Capital Leases has averaged $415000.0 across 3 years, with a median of $529000.0 in 2026.
• On a YoY basis, Capital Leases climbed as much as 66.17% in 2025 and fell as far as 66.17% in 2025.
• Evommune's Capital Leases stood at $535000.0 in 2024, then sank by 66.17% to $181000.0 in 2025, then soared by 192.27% to $529000.0 in 2026.
• Business Quant data shows EVMN's Capital Leases at $529000.0 in Q1 2026, $181000.0 in Q4 2025, and $535000.0 in Q4 2024.